Concern regarding the Surviving Sepsis Campaign (SSC) guidelines dates back to their inception. Guideline development was sponsored by Eli Lilly and Edwards Life Sciences as part of a commercial marketing campaign (1). Throughout its history, the SSC has a track record of conflicts of interest, making strong recommendations based on weak evidence, and being poorly responsive to new evidence (2-6).
The original backbone of the guidelines was a single-center trial by Rivers defining a protocol for early goal-directed therapy (7). Even after key elements of the Rivers protocol were disproven, the SSC continued to recommend them. For example, SSC continued to recommend the use of central venous pressure and mixed venous oxygen saturation after the emergence of evidence that they were nonbeneficial (including the PROCESS and ARISE trials). These interventions eventually fell out of favor, despite the slow response of SSC that delayed knowledge translation.
SSC has been sponsored by Eli Lilly, manufacturer of Activated Protein C. The guidelines continued recommending Activated Protein C until it was pulled from international markets in 2011. For example, the 2008 Guidelines recommended this, despite ongoing controversy and the emergence of neutral trials at that time (8,9). Notably, 11 of 24 guideline authors had financial conflicts of interest with Eli Lilly (10).
The Infectious Disease Society of America (IDSA) refused to endorse the SSC because of a suboptimal rating system and industry sponsorship (1). The IDSA has enormous experience in treating infection and creating guidelines. Septic patients deserve a set of guidelines that meet the IDSA standards.
Guidelines should summarize evidence and provide recommendations to clinicians. Unfortunately, the SSC doesn’t seem to trust clinicians to exercise judgement. The guidelines infantilize clinicians by prescribing a rigid set of bundles which mandate specific interventions within fixed time frames (example above). These recommendations are mostly arbitrary and unsupported by evidence (11,12). Nonetheless, they have been adopted by the Centers for Medicare & Medicaid Services as a core measure (SEP-1). This pressures physicians to administer treatments despite their best medical judgment (e.g. fluid bolus for a patient with clinically obvious volume overload).
We have attempted to discuss these issues with the SSC in a variety of forums, ranging from personal communications to formal publications (13-15). We have tried to illuminate deficiencies in the SSC bundles and the consequent SEP-1 core measures. Our arguments have fallen on deaf ears.
We have waited patiently for years in hopes that the guidelines would improve, but they have not. The 2018 SSC update is actually worse than prior guidelines, requiring the initiation of antibiotics and 30 cc/kg fluid bolus within merely sixty minutes of emergency department triage (16). These recommendations are arbitrary and dangerous. They will likely cause hasty management decisions, inappropriate fluid administration, and indiscriminate use of broad-spectrum antibiotics. We have been down this path before with other guidelines that required antibiotics for pneumonia within four hours, a recommendation that harmed patients and was eventually withdrawn (17).
It is increasingly clear that the SSC guidelines are an impediment to providing the best possible care to our septic patients. The rigid framework mandated by SSC doesn’t help experienced clinicians provide tailored therapy to their patients. Furthermore, the hegemony of these guidelines prevents other societies from developing better guidelines.
We are therefore petitioning for the retirement of the SSC guidelines. In its place, we would call for the development of separate sepsis guidelines by the United States, Europe, ANZICS, and likely other locales as well. There has been a monopoly on sepsis guidelines for too long, leading to stagnation and dogmatism. We would hope that these new guidelines are written by collaborations of the appropriate professional societies, based on the highest evidentiary standards. The existence of several competing sepsis guidelines could promote a diversity of opinions, regional adaptation, and flexible thinking about different approaches to sepsis.
We are disseminating an international petition that will allow clinicians to express their displeasure and concern over these guidelines. If you believe that our septic patients deserve more evidence-based guidelines, please stand with us.
Sincerely,
Scott Aberegg MD MPH
Jennifer Beck-Esmay MD
Steven Carroll DO MEd
Joshua Farkas MD
Jon-Emile Kenny MD
Alex Koyfman MD
Michelle Lin MD
Brit Long MD
Manu Malbrain MD PhD
Paul Marik MD
Ken Milne MD
Justin Morgenstern MD
Segun Olusanya MD
Salim Rezaie MD
Philippe Rola MD
Manpreet Singh MD
Rory Speigel MD
Reuben Strayer MD
Anand Swaminathan MD
Adam Thomas MD
Scott Weingart MD
Lauren Westafer DO MPH
Please consider signing the online petition here.
Related: Why the 2018 SSC update is based on flawed logic:
- The Case of the Temporal Fallacy (EMNerd)
- The fallacy of time-to-intervention studies (PulmCrit)
References
- Eichacker PQ, Natanson C, Danner RL. Surviving Sepsis – Practice guidelines, marketing campaigns, and Eli Lilly. New England Journal of Medicine 2006; 16: 1640-1642.
- Pepper DJ, Jaswal D, Sun J, Welsch J, Natanson C, Eichacker PQ. Evidence underpinning the Centers for Medicare & Medicaid Services’ Severe Sepsis and Septic Shock Management Bundle (SEP-1): A systematic review. Annals of Internal Medicine 2018; 168: 558-568.
- Finfer S. The Surviving Sepsis Campaign: Robust evaluation and high-quality primary research is still needed. Intensive Care Medicine 2010; 36: 187-189.
- Salluh JIF, Bozza PT, Bozza FA. Surviving sepsis campaign: A critical reappraisal. Shock 2008; 30: 70-72.
- Eichacker PQ, Natanson C, Danner RL. Separating practice guidelines from pharmaceutical marketing. Critical Care Medicine 2007; 35: 2877-2878.
- Hicks P, Cooper DJ, Webb S, Myburgh J, Sppelt I, Peake S, Joyce C, Stephens D, Turner A, French C, Hart G, Jenkins I, Burrell A.The Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. An assessment by the Australian and New Zealand Intensive Care Society. Anaesthesia and Intensive Care 2008; 36: 149-151.
- Rivers ME et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. New England Journal of Medicine 2001; 345: 1368-1377.
- Wenzel RP, Edmond MB. Septic shock – Evaluating another failed treatment. New England Journal of Medicine 2012; 366: 2122-2124.
- Savel RH, Munro CL. Evidence-based backlash: The tale of drotrecogin alfa. American Journal of Critical Care 2012; 21: 81-83.
- Dellinger RP, Levy MM, Carlet JM et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock. Intensive Care Medicine 2008; 34: 17-60.
- Allison MG, Schenkel SM. SEP-1: A sepsis measure in need of resuscitation? Annals of Emergency Medicine 2018; 71: 18-20.
- Barochia AV, Xizhong C, Eichacker PQ. The Surviving Sepsis Campaign’s revised sepsis bundles. Current Infectious Disease Reports 2013; 15: 385-393.
- Marik PE, Malbrain MLNG. The SEP-1 quality mandate may be harmful: How to drown a patient with 30 ml per kg fluid! Anesthesiology and Intensive Therapy 2017; 49(5) 323-328.
- Faust JS, Weingart SD. The past, present, and future of the centers for Medicare and Medicaid Services quality measure SEP-1: The early management bundle for severe sepsis/septic shock. Emergency Medicine Clinics of North America 2017; 35: 219-231.
- Marik PE. Surviving sepsis: going beyond the guidelines. Annals of Intensive Care 2011; 1: 17.
- Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Intensive Care Medicine. Electronic publication ahead of print, PMID 29675566.
- Kanwar M, Brar N, Khatib R, Fakih MG. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest 2007; 131: 1865-1869.
- Pulmcrit wee: The cutoff razor - April 15, 2024
- PulmCrit Blogitorial – Use of ECGs for management of (sub)massive PE - March 24, 2024
- PulmCrit Wee: Propofol induced eyelid opening apraxia – the struggle is real - March 20, 2024
Amen!
Great work folks, please keep this up. As an out of hospital critical care provider working in transport, we regularly see interfacility rescues necessitated by SSC. Now, these fallacies are dripping all the way down to prehospital providers in some cases- mandating they start SSC with their mere assessment of vital signs. In a world where critical thinking is being sucked out of medicine everywhere you turn, we have to take a stand.
You are all absolutely right!
Bruno, from Brazil, intensivist, associate director of the Critical Care program at Hospital das Clinicas, University of São Paulo Medical School
Fantastic post. Thank you for this- perhaps make the link to the petition a bit easier to find to make sure that as many people as possible sign this important petition.
Done. Thanks for the advice.
Totally agree with the retirement of these guidelines. They have led to inappropriate use of antibiotics in haste, departments have been penalised and resources misdirected.
Never loved the guidelines but I still think they have saved lives and increased sepsis awareness. They also help with medical education—each recommendation can be looked at individually and the reasoning and controversy behind each recommendation can be discussed with the learner. Would like to see new guidelines made before we retire the old.
yep, the most realistic scenario for how to replace the SSC guidelines is as follows:
1. People realize that the SSC guidelines are bad, This creates a power vacuum.
2. A critical care society creates guidelines that are better than SSC (e.g. Canadian Sepsis Guidelines).
3. It is widely recognized that the new guidelines are a big improvement compared to the old SSC guidelines.
4. SSC guidelines continue to lose traction and influence.
5. Other societies stop endorsing the SSC guidelines. Some of these societies may make their own guidelines.
thank you , Josh. i find all this, all these conversations, regarding sepsis quite interesting. the sides taken, the strong feelings regarding what is the perceived “truth”. they are for the most part, i think, serious considerations by serious people who are striving for a better treatment plan, and results. what is interesting too are the differences of opinion and understanding of definitions, and plans for behavior/treatment. who is making these? what is sepsis? shock? what is the role of SIRS, qSofa? what is the value of lactic acid? what numbers are “important”? it was recently mentioned at our ED… Read more »
The idea of giving 30 cc/kg fluid in the field is absolutely horrid, it reminds me a bit of pre-hospital cooling of post-arrest patients (remember how that went: https://pulmccm.org/randomized-controlled-trials/pre-hospital-hypothermia-hurt-not-helped-cardiac-arrest/)
I don’t think anyone knows the perfect way to manage these patients, I certainly don’t claim to. In the midst of this uncertainty, we need guidelines & regs that reflect how heterogeneous and dynamic these patients are.
Glad to hear this being discussed and I wholeheartedly agree. Martin Tobin [of the Tobin Index (RSBI)] was giving lectures about the influence of Big Pharma some ~10 yrs ago with Surviving Sepsis as a primary case study. At the time, he was viewed by many as needlessly contrarian and antiquated in his concern, but cogent thinking will never go out of style. These conversations are so key in this day and age of quality metrics (VAP, CAUTI, etc etc etc)– well intentioned but potentially harmful especially when reimbursement is linked to questionable standards. Frontline clinicians need to have a… Read more »
Indeed. I had thought that industry involvement in the sepsis guidelines faded out over time, but this doesn’t seem to be the case: https://www.bmj.com/content/360/bmj.k703
Thanks for doing this. This area has been crying for leadership for a while now.
I think we also ought to express our displeasure separately to the CMMS about the SEP-1 bundle mandates.
Thank you. To be honest, I did not know that the SSC were industry sponsored. As you mention above, every patient deserves a tailored approach. It isn’t even difficult to do that. I’ve got the feeling that the root of many strict guidelines is ATLS. (I know I am a little bit thought incongruent now). But even that system does not really work in clinical practice. What would be an alternative? We need something. As much Rivers EGDT is criticized, it woke up many of us and gave us an incentive to think sepsis. Yes, SSC is flawed, yes it… Read more »
Has EMCrit discussed/posted regarding their take on the publication from the NYS department of Health study: “Time to Treatment and Mortality during Mandated Emergency Care for Sepsis”? I would love to see a review of the study, since this study is the basis of the new SSC 2018 update. Thanks.
Time-to-intervention studies are hypothesis-generating ONLY. The concept of using this sort of data to create policy boggles the mind. For more on this issue, which is a persistent lesion in the medical literature:
https://emcrit.org/pulmcrit/the-fallacy-of-time-to-intervention-studies/
Keep fighting the good fight. There is rigorously collected data and there is expert opinion. We need more of the former and less of the latter.
WE HAVE “SEPSIS POLICE”( ICU NURSES) THAT ARE CONSTANTLY HOUNDING US FOR 30ML/KG FLUIDS ON ELDERLY PATIENTS, JUST BECAUSE PATIENTS LACTIC ACID IS ELEVATED .;LACTIC ACID CAN BE ELEVATED FROM CHF,METFORMIN,SEIZURE.,ALCOHOLIC CIRRHOSIS.I WAS REPORTED BECAUSE I WAS GIVING BLOOD AND PLATELETS,RATHER THAN 30ML/KG FLUIDS FOR UPPER GI BLEED IN A CIRRHOTIC WHO HAD 4+PITTING EDEMA AND ASCITES.